10 Best Innovative Healthcare Stocks to Buy Now

7. Alcon Inc. (NYSE:ALC)

Number of Hedge Fund Holders: 46

Alcon Inc. (NYSE:ALC) is one of the best healthcare stocks on our list.

TheFly reported on July 2 that Argus lowered its price target on ALC to $85 from $90 while maintaining a Buy rating on the shares. The firm noted that ALC’s stock is trading significantly below its historical highs and averages, creating a potential valuation opportunity. The company’s improved earnings outlook, with management forecasting 10%-13% growth in 2026 compared with flat performance in 2025, is supported by a strong late-stage product pipeline. Argus highlighted upcoming regulatory submissions expected in 2027 and 2028 as a factor supporting expectations for continued long-term growth.

In other news, on July 6, Alcon Inc. (NYSE:ALC) and RxSight (RXST) announced a non-exclusive collaboration to develop adjustable presbyopia-correcting intraocular lenses (PCIOLs). The partnership will combine RxSight’s post-operative light-adjustable technology with ALC’s PCIOL optical designs to create a platform aimed at improving vision outcomes for cataract patients. Under the agreement, RxSight will receive a $60 million upfront payment to support development activities and may earn up to an additional $140 million through development and regulatory milestones. ALC will oversee global commercialization efforts, while RxSight will manage development and manufacturing responsibilities and receive royalties from product sales.

Alcon Inc. (NYSE:ALC) is a global leader in eye care, developing advanced surgical devices, intraocular lenses (IOLs), and vision care products across 140+ countries. The company focuses on innovation through digital and robotic surgery, next-generation IOL platforms like Clareon, and virtual reality training tools to improve eye care outcomes.